# Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)

> **NCT06143748** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 46 (estimated)

## Conditions studied

- Esophagus Cancer

## Interventions

- **DRUG:** Cadonilimab
- **DRUG:** Paclitaxel and cisplatin
- **RADIATION:** intensity-modulated radiotherapy

## Key facts

- **NCT ID:** NCT06143748
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-02
- **Primary completion:** 2026-06-10
- **Final completion:** 2027-12-31
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06143748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06143748, "Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06143748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*